Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Determination of the digestive tolerability of the PROMITOR® in children from 3 to 7 years old.
The aim of the trial is to determine, using a dose escalation design, the digestive tolerability of the PROMITOR®given at the doses of 6, then 9 and finally 12 g (corresponding to 4, 6, and 8 g of fibers respectively) twice a day with the meals of the morning and of the evening versus control (maltodextrin, no fiber) over one week of intake in children from 3 to 7 years old.
As it is an exploratory study there is no categorization between primary and secondary objectives.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Placebo | Placebo Comparator | Placebo |
|
| Dose 1 - Promitor® | Active Comparator | Investigational product Dose 1 |
|
| Dose 2 - Promitor® | Active Comparator | Investigational product Dose 2 |
|
| Dose 3 - Promitor® | Active Comparator | Investigational product Dose 3 |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Placebo (including Maltodextrin) | Drug |
| ||
| Dose 1 - Promitor® |
| Measure | Description | Time Frame |
|---|---|---|
| Assessment of the digestive tolerability of the Investigational Product (abdominal pain) using analog visual scale | Using analog visual scale | 7 days of intake |
| Assessment of the digestive tolerability of the Investigational Product (rumbling) using analog visual scale | Using analog visual scale | 7 days of intake |
| Assessment of the digestive tolerability of the Investigational Product (bloating) using analog visual scale | Using analog visual scale | 7 days of intake |
| Assessment of the digestive tolerability of the Investigational Product (flatulence) using analog visual scale | Using analog visual scale | 7 days of intake |
| Assessment of the digestive tolerability of the Investigational Product (stools consistency & frequency) using analog visual scale | Using analog visual scale | 7 days of intake |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Biofortis | Saint-Herblain | 44800 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012817 | Signs and Symptoms, Digestive |
| ID | Term |
|---|---|
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Dose 2 - Promitor® | Drug |
|
| Dose 3 - Promitor® | Drug |
|